Tetrandrine suppresses the growth of human osteosarcoma cells by regulating multiple signaling pathways

References

• Rosen G, Tan C, Sanmaneechai A, et al. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma. Cancer. 2015;35(S3):936–945.
   Web of Science ®Google Scholar
• Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet. 2003;14(1–2):1–30.
   Google Scholar
• Jaffe N, Bruland OS, Bielack S (2010). [cancer treatment and research] pediatric and adolescent osteosarcoma volume 152 || osteosarcoma: review of the past, impact on the future. the american experience. 10.1007/978-1-4419-0284-9(Chapter 12), 239-262.
   Google Scholar
• Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49(6):1221–1230.
   PubMed Web of Science ®Google Scholar
• Benjamin RS. Adjuvant and neoadjuvant chemotherapy for osteosarcoma: a historical perspective. Adv Exp Med Biol. 2020;1257:1–10.
   PubMed Web of Science ®Google Scholar
• Bajelan E, Haeri A, Vali AM, et al. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance. J Pharm Pharm Sci. 2012;15(4):568–582.
   PubMed Web of Science ®Google Scholar
• Lee MS, Jeong MH, Lee HW, et al. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun. 2015;6(1):7769.
   PubMed Web of Science ®Google Scholar
• Chew MH, Tan WS, Liu Y, et al. Genomics of Hereditary Colorectal Cancer: lessons Learnt from 25 Years of the Singapore Polyposis Registry. Ann Acad Med Singap. 2015 Aug;44(8):290–296.
   PubMed Web of Science ®Google Scholar
• Xiao F, Liu B, Zhu QX. c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells. World J Gastroenterol. 2012 Dec 28;18(48):7348–7356.
   PubMed Web of Science ®Google Scholar
• Tang C, Liang J, Qian J, et al. Opposing role of JNK-p38 kinase and ERK1/2 in hydrogen peroxide-induced oxidative damage of human trophoblast-like JEG-3 cells. Int J Clin Exp Pathol. 2014 Feb 15;7(3):959–968.
   PubMed Web of Science ®Google Scholar
• Lee JA, Jung JS, Kim DH, et al. RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma. Pediatr Blood Cancer. 2011;56(5):738–743.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu X, Li W. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget. 2016 Jun 28;7(26):40800–40815.
   PubMedGoogle Scholar
• Jj L, Bao JL, Chen XP, et al. Alkaloids isolated from natural herbs as the anticancer agents. Evid Based Complement Alternat Med. 2012;2012:485042.
   PubMed Web of Science ®Google Scholar
• Shi DX, Ma LM, Lu YJ, et al. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):723–728.
   PubMedGoogle Scholar
• Wu JM, Chen Y, Chen JC, et al. Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett. 2010;287(2):187–195.
   PubMed Web of Science ®Google Scholar
• Li X, Su B, Liu R, et al. Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res. 2011;166(1):e45–51.
   PubMed Web of Science ®Google Scholar
• Liu C, Gong K, Mao X, et al. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer. 2011 Sep 15;129(6):e45–e51.
   PubMed Web of Science ®Google Scholar
• Luan F, He X, Zeng N. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. J Pharm Pharmacol. 2020 Nov;72(11):1491–1512.
   PubMed Web of Science ®Google Scholar
• He BC, Gao JL, Zhang BQ, et al. Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol. 2011;79(2):211–219.
   PubMed Web of Science ®Google Scholar
• Gao JL, Ji X, He TC, et al. Tetrandrine Suppresses Cancer Angiogenesis and Metastasis in 4T1 Tumor Bearing Mice. Evid Based Complement Alternat Med. 2013;2013:265061.
   PubMed Web of Science ®Google Scholar
• Gupta J, del Barco Barrantes I, Igea A, et al. Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell. 2014;25(4):484–500.
   PubMed Web of Science ®Google Scholar
• Grossi V, Peserico A, Tezil T, et al. p38alpha MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol. 2014;20(29):9744–9758.
   PubMed Web of Science ®Google Scholar
• Ishiyama M, Tominaga H, Shiga M, et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull. 1996;19(11):1518–1520.
   PubMed Web of Science ®Google Scholar
• Wang N, Liu W, Tan T, et al. Notch signaling negatively regulates BMP9-induced osteogenic differentiation of mesenchymal progenitor cells by inhibiting JunB expression. Oncotarget. 2017;8(65):109661–109674.
   PubMedGoogle Scholar
• Luo Q, Kang Q, Si W, et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004;279(53):55958–55968.
   PubMed Web of Science ®Google Scholar
• Zhou L, An N, Jiang W, et al. Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. BioTechniques. 2002;33(5):1126–1128. 1130, 1132 passim.
   PubMed Web of Science ®Google Scholar
• Xu H, Li X, Kong H, et al. Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line. J Biomed Nanotechnol. 2016 Aug;12(8):1699–1707.
   PubMed Web of Science ®Google Scholar
• McCubrey JA, Steelman LS, Bertrand FE, et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014;5(10):2881–2911.
   PubMedGoogle Scholar
• Zhao P, Li Q, Shi Z, et al. GSK-3beta regulates tumor growth and angiogenesis in human glioma cells. Oncotarget. 2015;6(31):31901–31915.
   PubMedGoogle Scholar
• Leelahavanichkul K, Amornphimoltham P, Molinolo AA, et al. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol Oncol. 2014;8(1):105–118.
   PubMed Web of Science ®Google Scholar
• Conley-lacomb MK, Saliganan A, Kandagatla P, et al. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Mol Cancer. 2013;12(1):85.
   PubMed Web of Science ®Google Scholar
• Heymann MF, Brown HK, Heymann D. Drugs in early clinical development for the treatment of osteosarcoma. Expert Opin Investig Drugs. 2016;25(11):1265–1280.
   PubMed Web of Science ®Google Scholar